Industry News
Discussions About End-Of-Life Care Between Physicians And Terminally Ill Cancer Patients Often Delayed Too Long
Feb 12, 2012
The vast majority of patients with incurable lung or colorectal cancer talk with a physician about their options for care at the end of life, but often not until late in the course of their illness, according to a new study by Dana-Farber Cancer Institute investigators published in the Annals of Internal Medicine... Read More
Chemotherapy Works Better With Short Fasting Periods
Feb 11, 2012
According to a study published in Science Translational Medicine, part of the Science family of journals, chemotherapy drugs are more effective when combined with cycles of short, severe fasting. Furthermore, fasting on its own was shown to be effective at treating most of the cancers tested in animals, including human cancer cells... Read More
Heart Disease May Be A Risk Factor For Prostate Cancer
Feb 11, 2012
In a large analysis of men participating in a prostate drug trial, researchers at the Duke Cancer Institute found a significant correlation between coronary artery disease and prostate cancer, suggesting the two conditions may have shared causes... Read More
Highlighting A Rare Subset Of Diseases Involving The Lymphatic System
Feb 11, 2012
A clinically challenging and under-studied subset of diseases affecting the lymphatic system and grouped under the disease spectrum lymphangiomatosis and Gorham's disease is the focus of a special issue of Lymphatic Research and Biology, a peer-reviewed journal published by Mary Ann Liebert, Inc.. The issue is available free online... Read More
Exercise Benefits Advanced Cancer Patients With Reduced Muscle Mass
Feb 11, 2012
Many patients with advanced cancer suffer from cachexia, a condition also called body-wasting or wasting syndrome, which causes significant weight loss, extreme fatigue and reduces quality of life... Read More
Research Suggests New Pathways For Cancer Progression
Feb 11, 2012
Observing that certain cancer cells may exhibit greater flexibility than normal cells, some scientists believe that this capability promotes rapid tumor growth. Now computer simulations developed by Boston University Biomedical Engineering Assistant Professor Muhammad Zaman and collaborators at the University of Texas at Austin appear to support this view... Read More
Heart Disease May Be A Risk Factor For Prostate Cancer
Feb 11, 2012
In a large analysis of men participating in a prostate drug trial, researchers at the Duke Cancer Institute found a significant correlation between coronary artery disease and prostate cancer, suggesting the two conditions may have shared causes... Read More
Highlighting A Rare Subset Of Diseases Involving The Lymphatic System
Feb 11, 2012
A clinically challenging and under-studied subset of diseases affecting the lymphatic system and grouped under the disease spectrum lymphangiomatosis and Gorham's disease is the focus of a special issue of Lymphatic Research and Biology, a peer-reviewed journal published by Mary Ann Liebert, Inc.. The issue is available free online... Read More
Chemotherapy During Pregnancy Does Not Risk The Child's General Health
Feb 10, 2012
A recent study published by the The Lancet Oncology indicates that children of women who received chemotherapy during their pregnancy suffer no adverse effects, developing as well as children in the general population. The study was led by Dr Frédéric Amant, Multidisciplinary Breast Cancer Center, Leuven Cancer Institute, Katholieke Universiteit Leuven, Belgium... Read More
Cancer Drug Reverses Symptoms Of Alzheimer's In Mice
Feb 10, 2012
A drug approved for the treatment of cancer appears to quickly reverse the symptoms of Alzheimer's in mice, according to a new study from the US published in the journal Science on Thursday. The Food and Drug Administration (FDA) approved bexarotene as a treatment for cutaneous T cell lymphoma, a type of skin cancer, in 2000... Read More
Previous Page Next Page